Index by author
October 01, 1995; Volume 275,Issue 1
Yamawaki, S
- You have accessModulation by sigma ligands of intracellular free Ca++ mobilization by N-methyl-D-aspartate in primary culture of rat frontal cortical neurons.T Hayashi, A Kagaya, M Takebayashi, M Shimizu, Y Uchitomi, N Motohashi and S YamawakiJournal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 207-214;
Yang, X Y
- You have accessThe endothelin receptor profile in L6 myotubes.Z Fekete, X Y Yang, M Kimura and A AvivJournal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 215-218;
Yasuhara, M
- You have accessCepharanthin, a multidrug resistant modifier, is a substrate for P-glycoprotein.M Hirai, K Tanaka, T Shimizu, Y Tanigawara, M Yasuhara, R Hori, Y Kakehi, O Yoshida, K Ueda and T KomanoJournal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 73-78;
Yen, W C
- You have accessRole of Na+ in the asymmetric paracellular transport of 4-phenylazobenzyloxycarbonyl-L-Pro-L-Leu-Gly-L-Pro-D-Arg across rabbit colonic segments and Caco-2 cell monolayers.W C Yen and V H LeeJournal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 114-119;
Yoshida, O
- You have accessCepharanthin, a multidrug resistant modifier, is a substrate for P-glycoprotein.M Hirai, K Tanaka, T Shimizu, Y Tanigawara, M Yasuhara, R Hori, Y Kakehi, O Yoshida, K Ueda and T KomanoJournal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 73-78;
Yuan, W
- You have accessPotent and selective inhibitors of leukotriene A4 hydrolase: effects on purified enzyme and human polymorphonuclear leukocytes.A Wetterholm, J Z Haeggström, B Samuelsson, W Yuan, B Munoz and C H WongJournal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 31-37;
Zorn, S H
- You have accessZiprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.T F Seeger, P A Seymour, A W Schmidt, S H Zorn, D W Schulz, L A Lebel, S McLean, V Guanowsky, H R Howard and J A LoweJournal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 101-113;
In this issue
Advertisement